For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic review
William Burman, Jayne Ellis, Gila Hale, Katherine Hill
eClinicalMedicine  vol: 82  first page: 103148  year: 2025  
doi: 10.1016/j.eclinm.2025.103148

2. Genetic polymorphisms and adverse reactions to antituberculosis therapy
Hannah M Gunter, Phuti Choshi, Tafadzwa Chimbetete, Sarah Pedretti, Rannakoe J Lehloenya, Phumla Z Sinxadi, Marylyn D Ritchie, Elizabeth J Phillips, David W Haas, Jonny G Peter
Pharmacogenomics  vol: 26  issue: 5-6  first page: 207  year: 2025  
doi: 10.1080/14622416.2025.2509479

3. Risk factors associated with anti-tubercular therapy-induced hepatitis in human immunodeficiency virus seropositive and seronegative patients in India
Aneez Jamal KM, Ashutosh Bhosale, Muralidhar Varma, Rajesh Radhakrishnan
International Journal of Risk & Safety in Medicine  year: 2025  
doi: 10.1177/09246479251401359